Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Labopharm's once-daily tramadol approved in France

Jan. 19, 2005

Eszopiclone shows efficacy in insomnia associated with MDD

Jan. 19, 2005

New therapeutic candidates for the treatment of Alzheimer's disease

Jan. 18, 2005

Researchers at ACRAF present novel analgesic compounds

Jan. 18, 2005

AstraZeneca scientists describe new agents for the treatment of pain

Jan. 18, 2005

Combinations of modafinil and an antidepressant agent claimed by Cephalon

Jan. 18, 2005

Low-dose doxepin therapy shows promise in primary sleep maintenance insomnia

Jan. 18, 2005

PARP inhibitor reduces brain infarct size in rats

Jan. 17, 2005

KCNQ2 channel activators for epilepsy, neuropathic pain, etc.

Jan. 17, 2005

Long-term vitamin E supplementation reported to reduce mortality due to ALS

Jan. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026